BRIEF-Janux Therapeutics Closes Public Offering For Proceeds Of $402.5 Mln

Reuters
07 Dec 2024
BRIEF-Janux <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Closes Public Offering For Proceeds Of $402.5 Mln

Dec 6 (Reuters) - Janux Therapeutics Inc JANX.O:

  • JANUX THERAPEUTICS ANNOUNCES CLOSING OF UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS INCLUDING FULL EXERCISE OF UNDERWRITERS’ OPTION TO PURCHASE ADDITIONAL SHARES FOR TOTAL GROSS PROCEEDS OF $402.5 MILLION

Source text: ID:nBw12T2BYa

Further company coverage: JANX.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10